Compare Bio Protocol (BIO) vs Pieverse (PIEVERSE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Pieverse — how do they compare? Bio Protocol trades at Rp513.51 (market cap Rp1,15T, Rp260,42M 24h volume), while Pieverse trades at Rp12,178 (market cap Rp3,22T, Rp206,49M 24h volume). The key difference: Pieverse is far larger — about 2.8× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 265,6M / 1B PIEVERSE (27%) for Pieverse. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Pieverse for 4 Days on average.
| BIO | PIEVERSE | |
|---|---|---|
Market Cap | Rp1,15T | Rp3,22T |
Volume (24h) | Rp260,42M | Rp206,49M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 265,6M / 1B PIEVERSE (27%) |
Typical Hold Time | 16 Days | 4 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Pieverse (PIEVERSE) is currently trading at Rp12,122, with a bearish technical signal driven by moving averages, though oscillators are neutral. The price hovers near pivot point support levels, with RSI_6 indicating potential oversold conditions. Market cap stands at Rp3.22T, with a circulating supply of 265.6 million tokens (27% of max supply). No major protocol updates or ecosystem news are available.
Overall outlook is cautious due to bearish momentum and limited fundamental catalysts. Key opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity, high volatility, and absence of recent developments. Investors should monitor support breaks and trading volume shifts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Pieverse
Pieverse is an agent-native payment infrastructure for Web3, designed to make on-chain transactions verifiable, auditable, and compliant. Built on x402b rails, it timestamps value through on-chain invoices, receipts, and checks. This enables seamless payments that link blockchain activity to real-world requirements, such as tax reporting and financial audits.
Read more on PIEVERSE →
